13.25-13.30 pm - Opening
Welcome and introduction: Pr Eric Deutsch, Director of Gustave Roussy Radiation Oncology Department and INSERM UMR 1030
PRIMER ON CANCER IMMUNOLOGY, RADIATIONS AND IMMUNOTHERAPY
(Educational Session)
13.30-15.30 Part I
Tumor-associated macrophages from bench to bedside, Pr Alberto Mantovani, Istituto Clinico Humanitas, IT
Role of tertiary lymphoid structures in response to anti-cancer immunotherapy, Pr Antoine Italiano, Gustave Roussy, FR
Immunological cell death: inducers and enhancers, Pr Guido Kroemer, Cordeliers Research Center, FR
Mechanisms of interaction of radiotherapy with immunotherapy, Pr Silvia Formenti, Weill Cornell Medicine, USA
15.30-16.00 Coffee break
16.00-18.00 Part II
How to build on the top of current chemo-radiations and PD-L1 inhibitors? The NSCLC model, Pr Fabrice Barlési, Gustave Roussy, FR
Modulating DNA damage responses to enhance radiotherapy-immunotherapy combinations, Pr Kevin Harrington, Institute of Cancer Research, UK
Immunogenic cell death driven by radiotherapy – Mechanisms and implications, Dr Lorenzo Galluzzi, Weill Cornell Medicine, USA
MAIN PROGRAM
Keynote Presentation
18.00-20.00 COCKTAIL POSTER SESSION
This website uses cookies that are necessary to its functioning and required to achieve the purposes illustrated in the privacy policy. By accepting this OR scrolling this page OR continuing to browse, you agree to our privacy policy.